Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Tetramer Technologies,L.L.C. in June, 2022 for $562,662.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0014 | Phase II | 562,662 | June 14, 2022 | |||||||
A SBIR Phase II contract was awarded to BRIMROSE TECHNOLOGY CORPORATION in September, 2021 for $748,330.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911ST-21-C-0042 | Phase II | 748,330 | September 27, 2021 | |||||||
A SBIR Phase I contract was awarded to Spectral Sensor Solutions, Llc in February, 2021 for $167,416.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C-0022 | Phase I | 167,416 | February 9, 2021 | |||||||
A SBIR Phase I contract was awarded to Cmc Pharmaceuticals, Inc. in February, 2022 for $167,076.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-P-0006 | Phase I | 167,076 | February 14, 2022 | |||||||
A SBIR Phase I contract was awarded to Intellisense Systems, Inc. in March, 2022 for $167,485.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QX-22-P-0031 | Phase I | 167,485 | March 15, 2022 | |||||||
A SBIR Phase I contract was awarded to KeriCure in February, 2022 for $167,470.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-P-0003 | Phase I | 167,470 | February 22, 2022 | |||||||
A SBIR Phase II contract was awarded to Arisan Therapeutics in September, 2021 for $269,361.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR21-C-5001 | Phase II | 269,361 | September 25, 2021 | |||||||
A SBIR Phase II contract was awarded to Arzeda in August, 2022 for $1,118,433.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | HDTRA1-22-C-0038 | Phase II | 1,118,433 | August 29, 2022 | |||||||
A SBIR Phase I contract was awarded to SiO2 Medical Products, Inc. in May, 2021 for $160,501.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-21-C-0069 | Phase I | 160,501 | May 3, 2021 | |||||||
A SBIR Phase I contract was awarded to KEF Robotics Inc in March, 2022 for $167,489.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QX-22-P-0027 | Phase I | 167,489 | March 18, 2022 | |||||||
A SBIR Phase I contract was awarded to Rx Bandz in May, 2021 for $167,468.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-21-C-0065 | Phase I | 167,468 | May 12, 2021 | |||||||
A SBIR Phase I contract was awarded to MICROCONTINUUM, INC. in March, 2022 for $167,478.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0023 | Phase I | 167,478 | March 29, 2022 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in July, 2022 for $589,374.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0036 | Phase II | 589,374 | July 7, 2022 | |||||||
A SBIR Phase I contract was awarded to NanoSonic Inc. in January, 2019 for $150,000.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-19-P-0011 | Phase I | 150,000 | January 28, 2019 | |||||||
A SBIR Phase II contract was awarded to Vivonics, Inc. in September, 2021 for $382,572.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C-5002 | Phase II | 382,572 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to Lynntech Inc. in April, 2022 for $165,415.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0030 | Phase I | 165,415 | April 4, 2022 | |||||||
A SBIR Phase II contract was awarded to Lynntech Inc. in September, 2022 for $549,996.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0038 | Phase II | 549,996 | September 28, 2022 | |||||||
A SBIR Phase I contract was awarded to Ceracom, Inc. in August, 2021 for $167,462.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C0-035 | Phase I | 167,462 | August 19, 2021 | |||||||
A SBIR Phase I contract was awarded to Intellisense Systems, Inc. in November, 2021 for $167,494.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911-NF-22-P-0002 | Phase I | 167,494 | November 8, 2021 | |||||||
A SBIR Phase I contract was awarded to Lynntech Inc. in July, 2021 for $167,498.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C-0030 | Phase I | 167,498 | July 27, 2021 | |||||||
A SBIR Phase II contract was awarded to Ceracom, Inc. in September, 2022 for $549,933.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0040 | Phase II | 549,933 | September 28, 2022 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in January, 2022 for $708,981.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0002 | Phase II | 708,981 | January 20, 2022 | |||||||
A SBIR Phase II contract was awarded to Nanogriptech, Inc in August, 2018 for $480,558.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-18-C-0006 | Phase II | 480,558 | August 20, 2018 | |||||||
A SBIR Phase I contract was awarded to Skyhaven Systems, LLC in April, 2021 for $167,499.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C-0031 | Phase I | 167,499 | April 30, 2021 | |||||||
A SBIR Phase I contract was awarded to Zeteo Tech in November, 2021 for $167,459.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911-NF-22-P-0005 | Phase I | 167,459 | November 8, 2021 |